| [1] |
Medoff-Cooper B, Bakewell-Sachs S, Buus-Frank M, et al. The AWHONN near- term infant initiative：a conceptual framework for optimizing health for near-term infants. J Obstet Gynecol Neonatal Nurs, 2005, 34(6)：666-671.
|
| [2] |
Moutquin JM. Classification and heterogeneity of preterm birth. BJOG, 2003, 110(Suppl 20): 30-33.
|
| [3] |
Ilekis JV, Reddy UM, Roberts JM. Preeclampsia: a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci, 2007, 14(6)：508-523.
|
| [4] |
Belghiti J, Kayem G, Tsatsaris V, et al. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol, 2011, 205(5)：465.e1-e6.
|
| [5] |
Bombrys AE, Barton JR, Nowacki EA, et al. Expectant management of severe preeclampsia at less than 27 weeks′ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol, 2008, 199(3)：247.e1-e6.
|
| [6] |
Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks′ gestation: a randomized controlled trial. Obstet Gynecol, 1990, 76(6)：1070-1075.
|
| [7] |
Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks′ gestation: a randomized controlled trial. Am J Obstet Gynecol, 1994, 171(3)：818-822.
|
| [8] |
Magee LA, Yong PJ, Espinosa V, et al. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy, 2009, 28(3)：312-347.
|
| [9] |
Ganzevoort W, Rep A, Bousel GJ, et al. A randomized controlled trial comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe preeclampsia. BJOG, 2005, 112(10)：1358-1368.
|
| [10] |
Chammas MF, Nguyen TM, Li MA, et al. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery？. Am J Obstet Gynecol, 2000, 183(4)：853-858.
|
| [11] |
Haddad B, Deis S, Goffinet F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks′ gestation. Am J Obstet Gynecol, 2004, 190(6)：1590-1595
|
| [12] |
Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol, 2006, 30(1)：34-43.
|
| [13] |
Chua S, Redman CW. Prognosis for preeclampsia complicated by 5 g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol, 1992, 43(1)：9-12.
|
| [14] |
Newman MG, Robichaux AG, Stedman CM, et al. Perinatal outcomes in pre- eclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol, 2003, 188(1)：264-268.
|
| [15] |
Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol, 2002, 186(1)：66-71.
|
| [16] |
Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol, 2000, 95(1)：24-28.
|
| [17] |
Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev, 2010, 8(9)：CD008148.
|
| [18] |
Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol, 2007, 196(6)：514.e1-e9.
|
| [19] |
Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onset, severe preeclampsia; maternal outcome. BJOG, 2000, 107(10)：1252-1257.
|
| [20] |
Haddad B, Kayem G, Deis S, et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction？. Am J Obstet Gynecol, 2007, 196(3)：237.e1-e5.
|
| [21] |
Shear RM, Rinfert D, Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction？. Am J Obstet Gynecol, 2005, 192(4)：1119-1125.
|
| [22] |
Fenakel K, Kenakel G, Appleman Z, et al. Nifedipine in treatment of severe preeclampsia. Obstet Gynecol, 1991, 77(3)：331-337.
|
| [23] |
Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol, 2000, 183(1)：S1-S22.
|
| [24] |
ACOG Committee on Practice Bulletins－－Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol, 2002, 99(1)：159-167.
|
| [25] |
Oettle C, Hall D, Roux A, et al. Early onset severe preeclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG, 2005, 112(1)：84-88.
|
| [26] |
Bombrys AE, Barton JR, Habli M, et al. Expectant management of severe preeclampsia at 270/7-336/7 weeks′ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol, 2009, 26(6)：441-446.
|
| [27] |
Hall DR, Grove D, Carstens E. Early-preeclampsia: what proportion of women qualify for expectant management and if not, why not？. Eur J Obstet Gynecol Reprod Biol, 2006, 128(1-2): 169-174.
|
| [28] |
Nassar AH, Adra AA, Chakhtoura N, et al. Severe preeclampsia remote from term: labor induction or elective cesarean delivery？. Am J Obstet Gynecol, 1998, 179(5): 1210-1213.
|
| [29] |
Alexander JM, Bloom SL, McIntire DD, et al. Severe preeclampsia and the very-low birth weight infant: is induction of labor harmful？. Obstet Gynecol, 1999, 93(4)：485-488.
|
| [30] |
Blackwell SC, Redman ME, Tomlinson M, et al. Labor induction for the preterm severe pre-eclamptic patient: is it worth the effort？. J Matern Fetal Med, 2001, 10(5): 305-311.
|
| [31] |
Shah DM, Shenai JP, Vaughn WK. Neonatal outcome of premature infants of mothers with preeclampsia. J Perinatol, 1995, 15(4)：264-267.
|
| [32] |
Kurkinen-Raty M, Koivisto M, Jouppila P. Preterm delivery for maternal or fetal indications: maternal morbidity, neonatal outcome and late sequelae in infants. BJOG, 2000, 107(5)：648-655.
|
| [33] |
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009, 33(3): 130-137.
|
| [34] |
Simpson LL. Maternal medical disease: risk of antepartum fetal death. Seminars in Perinatology, 2002, 26(1)：42-50.
|
| [35] |
Kimberlin DF, Hauth JC, Owen J, et al. Indicated versus spontaneous preterm delivery: An evaluation of neonatal morbidity among infants weighing <1000 grams at birth. Am J Obstet Gynecol, 1999, 180(3 Pt 1)：683-689.
|
| [36] |
Bastek JA, Srinivas SK, Sammel MD, et al. Do neonatal outcomes differ depending on the cause of preterm birth？. A comparison between spontaneous birth and iatrogenic delivery for preeclampsia. Am J Perinatol, 2010, 27(2): 163-169.
|
| [37] |
Jelin AC, Cheng YW, Shaffer BL, et al. Early-onset preeclampsia and neonatal outcomes. J Matern Fetal Neonatal Med, 2010, 23(5)：389-392.
|
| [38] |
Petersen SG, Wong SF, Urs P et al. Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: perinatal and long-term outcomes. Aust N Z J Obstet Gynaecol, 2009, 49(1): 45-51.
|
| [39] |
Sezik M, Tuncay G, Yapar EG. Prediction of adverse neonatal outcomes in preeclampsia by absent or reversed end-diastolic flow velocity in the umbilical artery. Gynecol Obstet Invest, 2004, 57(2): 109-113.
|
| [40] |
Engineer N, Kumar S. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand, 2010, 89(9): 1174- 1181.
|
| [41] |
Ødegard RA, Vatten LJ, Nilsen ST, et al. Preeclampsia and fetal growth. Obstet Gynecol, 2000, 96(6)：950-955.
|
| [42] |
von Dadelszen P, Magee LA, Taylor EL, et al. Maternal hypertension and neonatal outcome among small for gestational age infants. Canadian Neonatal Network. Obstet Gynecol, 2005, 106(2)：335-339.
|
| [43] |
Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human feto- placental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta, 2004, 25(2-3)：103-113.
|
| [44] |
Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol Reprod, 2001, 64(4)：1033-1040.
|
| [45] |
Abman SH. Bronchopulmonary dysplasia：" a vascular hypothesis" . Am J Respir Crit Care Med, 2001, 164(10 Pt 1)：1755-1756.
|
| [46] |
Bose C, Van Marter LJ, Laughon M, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics, 2009, 124(3)：e450-e458.
|
| [47] |
Hansen AR, Barnés CM, Folkman J, et al. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr, 2010, 156(4)：532-536
|
| [48] |
Seidman DS, Laor A, Gale R, et al. Pre-eclampsia and off- spring′s blood pressure, cognitive ability and physical development at 17- years-of-age. Br J Obstet Gynaecol, 1991, 98(10)：1009-1014.
|
| [49] |
Cheng SW, Chou HC, Tsou KI, et al. Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome. Early Hum Dev, 2004, 76(1)：39-46.
|
| [50] |
Silveira RC, Procianoy RS, Koch MS, et al. Growth and neurodevelopment outcome of very low birth weight infants delivered by preeclamptic mothers. Acta Paediatr, 2007, 96(12)：1738-1742.
|
| [51] |
Strand KM, Heimstad R, Iversen AC, et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study. BMJ, 2013, 347：f4089
|